Patents by Inventor Rhall E. Pope

Rhall E. Pope has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10357607
    Abstract: An apparatus comprises receiving a user prompt in a blood glucose (BG) management device to start a determination of an effective correction factor, receiving sampled blood glucose data of a patient obtained during a specified time duration, including a time duration after delivery of an initial insulin correction bolus, determining the effective correction factor using the BG management device according to a determined decrease in the blood glucose level of the patient and an amount of insulin in the initial insulin correction bolus, and cancelling the determination of the effective correction factor if a blood glucose level of the patient is outside of a specified range of blood glucose levels.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: July 23, 2019
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael L. Blomquist, Rhall E. Pope
  • Publication number: 20160082188
    Abstract: An apparatus comprises receiving a user prompt in a blood glucose (BG) management device to start a determination of an effective correction factor, receiving sampled blood glucose data of a patient obtained during a specified time duration, including a time duration after delivery of an initial insulin correction bolus, determining the effective correction factor using the BG management device according to a determined decrease in the blood glucose level of the patient and an amount of insulin in the initial insulin correction bolus, and cancelling the determination of the effective correction factor if a blood glucose level of the patient is outside of a specified range of blood glucose levels.
    Type: Application
    Filed: December 8, 2015
    Publication date: March 24, 2016
    Inventors: Michael L. Blomquist, Rhall E. Pope
  • Patent number: 8208984
    Abstract: An apparatus comprises receiving a user prompt in a blood glucose (BG) management device to start a determination of an effective correction factor, receiving sampled blood glucose data of a patient obtained during a specified time duration, including a time duration after delivery of an initial insulin correction bolus, determining the effective correction factor using the BG management device according to a determined decrease in the blood glucose level of the patient and an amount of insulin in the initial insulin correction bolus, and cancelling the determination of the effective correction factor if a blood glucose level of the patient is outside of a specified range of blood glucose levels.
    Type: Grant
    Filed: March 9, 2010
    Date of Patent: June 26, 2012
    Assignee: Smiths Medical ASD, Inc.
    Inventors: Michael Blomquist, Rhall E. Pope
  • Publication number: 20100222765
    Abstract: An apparatus comprises receiving a user prompt in a blood glucose (BG) management device to start a determination of an effective correction factor, receiving sampled blood glucose data of a patient obtained during a specified time duration, including a time duration after delivery of an initial insulin correction bolus, determining the effective correction factor using the BG management device according to a determined decrease in the blood glucose level of the patient and an amount of insulin in the initial insulin correction bolus, and cancelling the determination of the effective correction factor if a blood glucose level of the patient is outside of a specified range of blood glucose levels.
    Type: Application
    Filed: March 9, 2010
    Publication date: September 2, 2010
    Applicant: Smiths Medical ASD, Inc.
    Inventors: Michael Blomquist, Rhall E. Pope
  • Patent number: 7734323
    Abstract: An apparatus comprising a user interface configured to generate an electrical signal to begin determination of an effective correction factor when prompted by a user, an input configured to receive sampled blood glucose data of a patient that is obtained during a specified time duration, including a time duration after delivery of an initial insulin correction bolus, and a controller in electrical communication with the input and the user interface. The controller includes a correction factor module configured for determining an effective correction factor according to an amount of insulin in the initial insulin correction bolus and a decrease in the blood glucose level determined using the sampled blood glucose data. Other devices and methods are disclosed.
    Type: Grant
    Filed: January 24, 2007
    Date of Patent: June 8, 2010
    Assignee: Smiths Medical ASD, Inc.
    Inventors: Michael Blomquist, Rhall E. Pope
  • Publication number: 20080177165
    Abstract: An apparatus comprising a user interface configured to generate an electrical signal to begin determination of an effective correction factor when prompted by a user, an input configured to receive sampled blood glucose data of a patient that is obtained during a specified time duration, including a time duration after delivery of an initial insulin correction bolus, and a controller in electrical communication with the input and the user interface. The controller includes a correction factor module configured for determining an effective correction factor according to an amount of insulin in the initial insulin correction bolus and a decrease in the blood glucose level determined using the sampled blood glucose data. Other devices and methods are disclosed.
    Type: Application
    Filed: January 24, 2007
    Publication date: July 24, 2008
    Inventors: Michael Blomquist, Rhall E. Pope
  • Publication number: 20080033360
    Abstract: An apparatus and method for indicating a current condition of a medical infusion pump is disclosed. The apparatus includes a memory configured to store two or more color codes, each color code corresponding to a condition of the medical infusion pump and a color. The apparatus further includes a monitor. The apparatus also includes a programmable circuit in electrical communication with the memory and the monitor, the programmable circuit programmed to generate a graphical user interface displaying a color upon detection of a condition. The method includes, upon detecting a condition in the medical infusion pump, displaying a color on a monitor associated to the medical infusion pump.
    Type: Application
    Filed: February 5, 2007
    Publication date: February 7, 2008
    Inventors: William James Evans, Michael L. Blomquist, Rhall E. Pope